User profiles for M. Merlos

Manuel Merlos

Head of Pharmacology
Verified email at welab.barcelona
Cited by 7062

Sigma 1 receptor: a new therapeutic target for pain

D Zamanillo, L Romero, M Merlos, JM Vela - European Journal of …, 2013 - Elsevier
Sigma 1 receptor (σ 1 receptor) is a unique ligand-regulated molecular chaperone located
mainly in the endoplasmic reticulum and the plasma membrane. σ 1 receptor is activated …

[HTML][HTML] Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction

M Rodríguez-Muñoz, P Sánchez-Blázquez, M Merlos… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Glutamate is probably the most important excitatory neurotransmitter in the brain. The glutamate
N-methyl-D-aspartate receptor (NMDAR) is a calcium-gated channel that coordinates …

Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of …

I Izquierdo, M Merlos… - Drugs of today (Barcelona …, 2003 - europepmc.org
Rupatadine is a new agent for the management of diseases with allergic inflammatory
conditions, such as seasonal and perennial rhinitis. The pharmacological profile of rupatadine …

[HTML][HTML] Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells

…, M Merlos, JC Laguna, M Vázquez-Carrera - Journal of biological …, 2008 - ASBMB
Here we report that in skeletal muscle cells the contribution to insulin resistance and
inflammation of two common dietary long-chain fatty acids depends on the channeling of these …

Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women: a randomized crossover trial

…, S Munoz, B Campero, E Casals, M Merlos… - Annals of internal …, 2000 - acpjournals.org
Background: It has been reported that walnuts reduce serum cholesterol levels in normal
young men. Objective: To assess the acceptability of walnuts and their effects on serum lipid …

New Azole Antifungals. 3. Synthesis and Antifungal Activity of 3-Substituted-4(3H)-quinazolinones

…, ML Vericat, L Conte, J Ramis, M Merlos… - Journal of medicinal …, 1998 - ACS Publications
… Parallel MM calculations 13 further indicated conformer m to be 2.1 kcal/mol higher in energy
than M (Figure 3). Contrarily, no difference in energy was found for the two corresponding …

Pharmacological properties of S1RA, a new sigma‐1 receptor antagonist that inhibits neuropathic pain and activity‐induced spinal sensitization

…, G Encina, J Burgueño, M Merlos… - British journal of …, 2012 - Wiley Online Library
BACKGROUND AND PURPOSE The sigma‐1 (σ 1 ) receptor is a ligand‐regulated molecular
chaperone that has been involved in pain, but there is limited understanding of the actions …

Palmitate induces tumor necrosis factor-α expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-κB activation

M Jové, A Planavila, RM Sánchez, M Merlos… - …, 2006 - academic.oup.com
The mechanisms responsible for increased expression of TNF-α in skeletal muscle cells in
diabetic states are not well understood. We examined the effects of the saturated acid …

Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)

M Merlos, M Giral, D Balsa, R Ferrando… - … of Pharmacology and …, 1997 - ASPET
… with [ 3 H]WEB-2086 (20 nM) for binding to platelet membranes was evaluated by adding
the antagonists at a minimum of eight appropriate concentrations between 10 −11 and 10 −5 M

Synthesis and SAR of a New Series of COX-2-Selective Inhibitors:  Pyrazolo[1,5-a]pyrimidines

…, LA Gómez, A Miralles, M Merlos… - Journal of medicinal …, 2001 - ACS Publications
The synthesis and pharmacological activity of a series of bicyclic pyrazolo[1,5-a]pyrimidines
as potent and selective cyclooxygenase-2 (COX-2) inhibitors are described. The new …